[unable to retrieve full-text content] Efficacy and safety of aticaprant, a kappa receptor antagonist, adjunctive to oral SSRI/SNRI antidepressant in major depressive disorder: results of a phase 2 randomized, double-blind, placebo-controlled study Nature.com
[unable to retrieve full-text content] Ketogenic metabolic therapy in the remission of chronic major depressive disorder: a retrospective case study Frontiers
Comments
Post a Comment